Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Liver transplantation Stories

2014-04-17 23:13:10

CPMC liver, kidney transplant programs earn recognition from transplant registry Sutter Health affiliate transplant team’s risk-adjusted survival rate is nation’s best. SAN FRANCISCO (PRWEB) April 17, 2014 Sutter Health affiliate California Pacific Medical Center (CPMC) has been identified as the nation’s only hospital with both kidney and liver transplant programs that have higher-than-expected one- and three-year adult patient survivals that are statistically better-than-expected....

2014-04-11 12:57:21

New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV). As part of a compassionate use program, 104 post-liver transplant patients with recurring HCV who had exhausted all treatment options and had poor clinical prognoses, received sofosbuvir (SOF) and ribavirin (RBV) with pegylated interferon (PEG) included at the physicians’ discretion for...

2014-04-11 00:21:56

LONDON, April 11, 2014 /PRNewswire/ -- - Hepatic encephalopathy (HE) is associated with a significant increase in mortality (58.1% vs. 32.4%), as well as longer hospital stays (8 days vs. 6.8 days) and more primary care visits (18.2 vs. 8.7 contacts per patient year) compared to similar liver patients without HE[i],[ii] - XIFAXAN(R) 550 (rifaximin-alpha) is a cost-effective treatment option for the...

2014-04-10 13:40:50

In the UK paracetamol toxicity is the most common cause of ALF and has a high mortality rate. It is estimated that 150 to 200 deaths and 15 to 20 LTs occur as a result of poisoning each year in England and Wales. LT is the definitive treatment for ALF patients who meet the criteria for transplantation but the current means of selection for LT (the King's College Criteria) are not ideal and do not assess changes in prognostic measures over time or quantify the mortality risk for individual...

2014-03-26 10:48:12

Among veterans meeting eligibility for liver transplantation, greater distance from a Veterans Affairs transplant center or any transplant center was associated with lower likelihood of being put on a waitlist or receiving a transplant, and a greater likelihood of death, according to a study in the March 26 issue of JAMA. Centralization of specialized health care services is used to control costs, concentrate expertise, and minimize regional differences in quality of care. Although...

2014-03-26 10:44:42

Findings reveal system of centralized transplantation care may place lives at risk Veterans with liver disease who live more than 100 miles from a Veterans Administration hospital that offers liver transplants are only half as likely to be placed on the liver transplant waitlist to receive a new organ compared to veterans who live closer to transplant centers, according to a new study from the Perelman School of Medicine of the University of Pennsylvania. The findings, which are published...

2014-03-19 23:26:37

Hepatitis B Foundation honors liver transplant pioneer with highest scientific honor. Doylestown, PA (PRWEB) March 19, 2014 The Hepatitis B Foundation (http://www.hepb.org) is pleased to announce that it has selected Thomas E. Starzl, M.D., Ph.D., to receive its 2014 Baruch S. Blumberg Prize, the highest scientific honor that it confers. The Pennsylvania-based foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B. The board of directors...

2014-03-18 08:26:31

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Liver Transplantation Global Clinical Trials Review, H2, 2013 Liver Transplantation Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Liver Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Liver Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2014-03-11 08:21:47

PARIS, March 11, 2014 /PRNewswire/ -- The OrganOx(TM) metraTM has won the Altran Foundation for Innovation 2013 international award. The OrganOx metra system, which was presented by Altran UK[1], is a revolutionary device which has been designed to keep livers in a physiological state for up to 24 hours. This is a major improvement over the conventional cold process currently used to preserve organs. This device will benefit from the support of a team of Altran experts, who,...

science laboratory
2014-02-24 05:23:59

Gladstone Institutes Joint Gladstone-UCSF study highlights novel reprogramming method; offers new hope for treating liver failure SAN FRANCISCO, CA—February 23, 2014 — The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells and even neurons. However, a method to generate cells that are fully mature—a crucial prerequisite for life-saving therapies—has proven far more difficult. But now,...